FDA withdraws multiple myeloma treatment after a confirmatory trial showed an increased risk of death; latest efficacy results for Abrysvo vaccine; chikungunya virus vaccine recommendations; Complete Response Letter issued to investigative schizophrenia treatment; new treatment for complicated UTIs including pyelonephritis; over-the-counter eye ointments recalled.
Please login or register first to view this content.